We are live on ! Find out more
XBIT icon

XBiotech
XBIT

60 hedge funds and large institutions have $102M invested in XBiotech in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

99% more capital invested

Capital invested by funds: $51.4M → $102M (+$50.8M)

28% more funds holding

Funds holding: 47 → 60 (+13)

1.34% more ownership

Funds ownership: 11.98% → 13.33% (+1.3%)

87% less call options, than puts

Call options by funds: $134K | Put options by funds: $1.05M

Holders
60
Holders Change
+13
Holders Change %
+27.66%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
25
Reduced
12
Closed
6
Calls
$134K
Puts
$1.05M
Net Calls
-$917K
Net Calls Change
+$111K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.22M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.26M
3
CAM
ClariVest Asset Management
California
+$2.09M
4
Millennium Management
Millennium Management
New York
+$1.57M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$5.45M
2
SI
Sofinnova Investments
California
-$1.52M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.3M
4
6CM
683 Capital Management
New York
-$628K
5
WG
Winton Group
United Kingdom
-$356K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$83K +$54.8K +4,253 +1,787%
Legal & General Group
52
Legal & General Group
United Kingdom
$75K +$4.89K +380 +11%
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$45K +$7.42K +576 +32%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$41.1K +$17.2K +1,333 +153%
MAM
55
Meeder Asset Management
Ohio
$40K +$27.6K +2,147 New
AIP
56
Ameritas Investment Partners
Nebraska
$28K – – –
Group One Trading
57
Group One Trading
Illinois
$13K -$157K -12,190 -94%
SFS
58
Sowell Financial Services
Arkansas
$7K +$4.51K +350 New
Daiwa Securities Group
59
Daiwa Securities Group
Japan
$4K +$2.99K +232 New
Federated Hermes
60
Federated Hermes
Pennsylvania
$1K +$567 +44 New
BBA
61
Baker Bros. Advisors
New York
– -$5.45M -521,327 Closed
6CM
62
683 Capital Management
New York
– -$628K -60,000 Closed
WG
63
Winton Group
United Kingdom
– -$356K -34,022 Closed
BC
64
Birchview Capital
Vermont
– -$314K -30,000 Closed
Victory Capital Management
65
Victory Capital Management
Texas
– -$35K -3,393 Closed
PA
66
Parallel Advisors
California
– -$2K -147 Closed
1 2
3

XBIT Hedge Fund Activity: Q4 2019 in Review

60 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2019, worth a combined $102M — up 99% from $51.4M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new XBIT positions and 6 closed out — a net gain of 13 holders — while 25 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $6.22M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $5.45M sold.

  • 60 institutional investors held XBiotech (XBIT) as of Q4 2019, up from 47 in Q3 2019.
  • Funds reported $102M of XBiotech stock for Q4 2019, up 99% quarter-over-quarter.
  • 19 funds opened new XBiotech positions in Q4 2019 and 6 closed out, a net change of +13 holders.
  • The largest XBiotech buyer in Q4 2019 was BlackRock, an estimated $6.22M added.
  • The largest XBiotech seller in Q4 2019 was Baker Bros. Advisors, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2019.